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WHAT IS NEW IN THE DIAGNOSIS OF TUBERCULOSIS?*
PART 1 : TECHNIQUES FOR DIAGNOSIS OF TUBERCULOSIS
R. Ramachandran1  and C.N. Paramasivan2
Despite the discovery of the tubercle bacillus
more than a hundred years ago, and all the advances
in our knowledge of the disease made since then,
tuberculosis still remains one of the major health
problems facing mankind, particularly in developing
countries.  Presently, about one third of the worlds
population is infected with Mycobacterium
tuberculosis.  It is estimated that currently there are
about 10 million new cases of tuberculosis every
year with 3 million deaths occurring world-wide1.
Currently, more people die of tuberculosis than from
any other infectious disease.  Death from tuberculosis
comprises 25% of all avoidable deaths in developing
countries.  Nearly 95% of all tuberculosis cases and
98% of deaths due to tuberculosis are in developing
countries and 75% of tuberculosis cases are in the
economically productive age group2 .  In India, out
of a total population of over 1 billion, each year about
2 million develop active disease and up to half a
million die3 .  It implies that every minute, a death
occurs due to tuberculosis in our country.  It also
imposes a cost on our economy in terms of current
and future output losses because of premature deaths
and ill health4 .  To add to the existing burden, the
situation is compounded by the large scale increase
of new TB cases associated with increasing HIV
infection.  India is estimated to have 3.5 million HIV
patients, and about 1.8 million of these are co-infected
with TB5.  The HIV seroprevalence among TB
patients in India ranges from around 2 to 20%, with
an estimated 60% of HIV infected persons breaking
down with active TB disease in their life-time6.  The
diagnosis of TB with HIV positive patients is more
difficult than in those without HIV infection.  These
issues need to be scrutinized when laboratories are
required to cater to this group of population.
Early diagnosis of tuberculosis and initiating
optimal treatment would not only enable a cure of
an individual patient but will also curb the
transmission of infection and disease to others in
the community.  Of the several distinct components
of the TB Control Programme, case finding remains
the corner stone for effective control7.  However,
there are no definite guidelines available as of today
as to how to use optimally the number of diagnostic
tests ranging from simple AFB microscopy to
complex molecular biological techniques which have
become available over a period, to establish or rule
out diagnosis of tuberculosis in a given patient.  The
present write-up gives, in two parts,  a brief
description of the important techniques available for
the (i) early diagnosis of tuberculosis, and (ii) drug
susceptibility testing.
There are two basic approaches for the
diagnosis of tuberculosis.  The direct approach
includes detection of mycobacteria or its products
and the indirect approach includes measurements of
humoral and cellular responses of the host against
tuberculosis.
The diagnostic modalities should have
certain desirable features viz. sensitivity, specificity,
predictive value, speed, reproducibility, cost
effectiveness, safety, simplicity, robustness and easy
application for wider use. Ideally, the tests should
be quantitative, at least in some measure, so that the
infectiveness of the individual cases can be measured.
This is especially important for decisions to isolate
hospitalized patients and to provide preventive
therapy to contacts.  Diagnostic modalities must also
be tailored to needs of the population and
epidemiology of TB in that region.  Epidemiologically,
the countries can be grouped as non-endemic or
endemic.  The diagnostic algorithms are planned as
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per specific needs and resources available in
individual countries.
The diagnostic needs in disease non-endemic
countries include identification of latent infection in
high risk groups, diagnosis of patients in early phase
of disease, faster detection of outbreaks (nosocomial
and community transmission), and finding out
patients with non-tuberculous mycobacterial disease.
The diagnostic needs in disease endemic countries
include improved microscopy, usage of liquid culture
for childhood and extra-pulmonary TB, chemical and
physical detection of mycobacterial antigens in
paucibacillary condition, antigen capture, antibody
detection, cellular immune recognition, nucleic acid
amplification, and phage assay.
The diagnosis in endemic countries
depends more on the use of labour intensive, easy
to use methodology with minimum infrastructure
or equipment.  The need is to find a viable
alternative for smear microscopy.  This method
has to have the following desirable features: results
within 2 hours,  simple training, easy
interpretation, should function well in HIV positive
patients and allow start of treatment as early as
possible.  Currently,  less than 20% of the nearly
10 million predicted annual cases of tuberculosis
are identified as smear positive.
DIRECT APPROACH
Microscopy: Microscopy is the simplest and most
rapid procedure currently available to detect acid-
fast bacilli (AFB) in clinical specimens by Ziehl-
Neelsen staining method or its modifications.  The
limit of detection with this method is that it requires
at least 5 x 103 bacilli per ml of sputum8.  Fluorescent
staining method offers the advantage of screening
the smear under low power where a large number
of slides is screened in less time.
The results of smear microscopy can be
influenced by the type of specimens, thickness of
the smear, extent of decolorisation, type of counter
stain used, and training and experience of the person
examining the smear.  Several approaches are being
made to enhance the sensitivity of the smear
microscopy.  Concentration of sputum sample by
cytocentrifugation has been found to enhance the
sensitivity to almost 100%9.  Liquefaction of sputum
with sodium hypochlorite followed by concentration
of bacilli by overnight sedimentations enhances the
sensitivity of smear microscopy close to 70%
compared to culture.  Similarly, treatment of sputum
samples with Zwitterionic detergent, also known as
C18 
carboxy-prophylbetaine (CB18) interferes with
the innate buoyancy of the bacilli and enhances the
result of smear microscopy10.
For  our country, the smear microscopy is
likely to remain for the foreseeable future, the only
cost effective tool for diagnosing patients with
infectious tuberculosis and to monitor the progress
of treatment.  Under the Revised National
Tuberculosis Control Programme (RNTCP),
Government of India has ensured good quality
sputum microscopy in all aspects in the entire
RNTCP implemented areas of the country.  This
includes training, enhancing manpower, developing
manuals, establishing uniform laboratory set up,
ensuring supply of good quality reagents and
microscopes and instituting quality control measures,
right from the microscopic centres up to the state
level laboratories. The various national tuberculosis
institutes of the country are made responsible for
monitoring the above-mentioned activities.
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The main advantages of smear 
microscopy: 
 
(i)  It is inexpensive, simple. 
 
(ii) It is relatively easy to perform 
and read and detects transmitters of 
tubercle bacilli. 
 
(iii) Results can be reported within  
hours of receipt of the sample. 
Provides reliable epidemiological 
indicators needed for the evaluation 
of the National Tuberculosis 
Control Programme. 
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Culture
Isolation of mycobacteria from clinical
samples by culture still represents the corner stone
on which definitive diagnosis of tuberculosis and
other mycobacterioses relies.  At present,
mycobacterial culture can be performed on
conventional egg based solid medium such as
Lowenstein-Jensen medium and agar based ones,
such as Middle brook 7H10 or 7H11 and liquid media
such as Kirschners or Middlebrook 7H9 broth.  The
major constraint of culturing mycobacteria in
conventional media is its slow growth which
necessitates a mean incubation period of at least 4
weeks11.  The drug susceptibility tests to anti-
tuberculosis drugs require additional 4 weeks.  Most
of the laboratories in the developing world rely on
solid media for culture of mycobacteria.  The choice
and preparation of specimens by various pretreatment
procedures has tremendous influence on the
sensitivity of results.  The positivity of culture largely
depends on the technique of decontamination used
by various laboratories, viz the chemicals used for
decontamination and the centrifugation method
adopted for processing specimens for culturing
mycobacteria by inoculating into solid or liquid
media.
Although a combination of solid and liquid
media is currently  the gold standard for the primary
isolation of mycobacteria, a few modern, rapid
methods are also available.  These include micro
colony detection on solid media (including the rapid
slide culture technique), septi-check AFB method,
microscopic observation of broth culture (MODS),
the BACTEC 460 radiometric system, BACTEC
MGIT 960 system (Becton Dickinson), MB/Bac T
system (Organon Teknika), and the ESP II culture
system.
Micro colony detection on solid media: In this
method, plates poured with thin layer of Middle-
brook 7H11 agar medium are incubated and examined
microscopically on alternate days for the first 2 days
and less frequently thereafter.  In less than 7 days,
micro colonies of slow growing mycobacteria such
as M.tuberculosis can be detected.  Though this
method is less expensive and requires about half the
time needed for conventional culture, the recovery
of mycobacteria is less efficient and it is labour
intensive.  Since M.tuberculosis grows more rapidly
in liquid medium forming strings and tangles, which
can be observed under the inverted light microscope
with 40x magnification, this method is a better
alternative for culturing tubercle bacilli12.
Septi-check AFB method : The septi-check AFB
system consists of a capped bottle containing 30.0
ml of Middlebrook 7H9 broth under enhanced (5-
8%) CO
2  
a paddle with agar media enclosed in a
plastic tube, and enrichment broth containing
glucose, glycerine, oleic acid, pyridoxal, catalase,
albumin, polyoxyethylene 40 stearate, azlocillin,
nalidixic acid, trimethoprim, polymyxin B and
amphotericin B.  One side of the paddle is covered
with non-selective Middlebrook 7H11 agar, the
reverse side is divided into two sections: one contains
7H11 agar with para-nitro-á-acetylamino-ß-
hydroxypropiophenone (NAP) for differentiation of
M.tuberculosis from other mycobacteria, the other
section contains chocolate agar for detection of
contaminants.  This non-radiometric approach has
the potential to expedite processing, obviate CO2
incubation requirements and facilitates early detection
of positive cultures.  This method requires about 3
weeks of incubation. The unique advantage of this
technique is the simultaneous detection of
M.tuberculosis, non-tuberculous mycobacteria
(NTM), other respiratory pathogens and even
contaminants.  A multicentric study conducted in
the USA has shown that the system gives a better
culture result when compared to other methods
including BACTEC 460 TB system13.
Radiometric BACTEC 460 TB method :  This
technique is specific for mycobacterial growth,
wherein 14C labelled palmitic acid in 7H12 medium is
used.  This system detects the presence of
mycobacteria based on their metabolism rather than
visible growth.  When the 14C labelled substrate
present in the medium is metabolized, 14CO2 is
produced and measured by the BACTEC system
instrument and reported in terms of growth index
(GI) value.  The BACTEC system is also useful in
the identification of M.tuberculosis using specific
inhibitor, para-nitro-á-acetylamino-ß-hydroxypro-
TECHNIQUES  FOR  DIAGNOSIS  OF  TUBERCULOSIS
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piophenone.  Using the same system, drug
susceptibility tests can also be performed for all the
anti tuberculosis drugs when sufficient GI is
observed.  Mycobacteria in clinical samples can be
detected in half the time compared to conventional
culture methods14.
A comparison of the BACTEC radiometric
method with the conventional culture and drug
susceptibility testing methods undertaken at the
Tuberculosis Research Centre (TRC), Chennai
showed that the rate of isolation of positive cultures
was significantly faster with the BACTEC method,
with 87% of the positives being obtained by 7 days
and 96% by 14 days.  There was a good correlation
in drug susceptibility tests and most of these results
could be obtained within 8 days by the BACTEC
method15.  By facilitating early diagnosis, the
BACTEC method may prove to be cost effective in
a population with high prevalence of tuberculosis.
MGIT 960 mycobacteria detection system : It is an
automated system for the growth and detection of
mycobacteria with a capacity to incubate and
continuously monitor 960 mycobacteria growth
indicator tubes (MGIT) every 60 minutes for increase
in fluorescence.  Growth detection is based on the
AFB metabolic O2
 
utilization and subsequent
intensification of an O2
 
quenched fluorescent dye
contained in a tube of modified MGIT.  A series of
algorithms are used to determine presumptive
positivity and alert the operator to the presence and
location of positive tubes.
In a multi-centre evaluation of the MGIT
960 system, three high volume testing sites in USA
compared the growth and recovery of
mycobacteria to that of BACTEC 460 TB and
conventional culture methods16.  Comparison of
average time of detection between paired
specimens showed that the BACTEC 460 and
MGIT 960 systems were 8.7 versus 8.6 days for
M.avium complex (MAC) and 13.4 versus 15.5
days for M.tuberculosis respectively.  It was
revealed that MGIT 960 system exhibits greater
potential as a rapid, accurate and cost effective
method for a high volume mycobacteriology
laboratory.
MB/BacT system : This is a non-radiometric
continuous monitoring system with a computerized
database management.  The system is based on
colorimetric detection of CO2.
Comparison of the performance of MB/
BacT system with that of BACTEC 460 showed that
the mean time for detection of M.tuberculosis by the
BACTEC system was 11.6 days vs 13.7 days by the
MB/BacT system.  It was concluded that the MB/
BacT with the computerized data management
system is an acceptable alternative for BACTEC 460
method despite some minor disadvantages such as
increased contamination and slightly longer time for
detection of growth17.
ESP culture system II : This is a fully automated
continuous monitoring system based on the detection
of pressure changes within the headspace above the
broth culture medium in a sealed bottle, i.e. either
gas production or gas consumption due to microbial
growth.  A special detection algorithm is present in
this system for the detection of very slowly growing
mycobacteria.
The system was evaluated in clinical
specimens for the detection of mycobacteria against
BACTEC 460 and 7H11 agar solid medium.  The
mean time for recovery of all mycobacteria,
M.tuberculosis complex and MAC was found to be
13.1, 15.5 and 10.9 days respectively.  Hence the
ESP II culture system seems to be a reliable non-
radiometric less labour-intensive alternative to
BACTEC 460 system for the growth and detection
of mycobacteria.  However, as with other liquid
culture systems, ESP II should be used in combination
with a solid medium, not as a stand-alone system18.
Microscopic observation of broth culture : This is a
rapid and relatively inexpensive method which
compares very well with other well established
systems in terms of both sensitivity and  specificity,
and also to some extent with speed when compared
to solid media.  Although this technique may be
appropriate for disease endemic high-burden
countries, it requires P2 Bio-safety cabinets, relatively
expensive Middlebrook 7H9 broth, oleic acid dextrose
catalase (OADC) and anti-microbial supplements and
R. RAMACHANDRAN  ET  AL
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a relatively high technical skill19.
IDENTIFICATION OF MYCOBACTERIAL
SPECIES
Mycobacterial speciation is carried out by
various methods ranging from conventional
biochemical tests to modern high-tech molecular
biological methods.  These can be broadly classified
as:
(i) Phenotypic characterization
(ii) Biochemical typing
(iii) Analysis of lipid: By gas
chromatography, mass spectrum and
high pressure liquid chromatography
(HPLC).
(iv) Probe based identification:  It includes
peptide nucleic acid (PNA)
fluorescence in situ hybridization assay
for identification of mycobacterial
species.  PNA is a novel DNA mimic in
which sugar phosphate backbone of
DNA has been replaced by a polyamide
backbone.  The uncharged nature and
high conformational flexibility of PNA
allows PNA probes to hybridize DNA
or RNA with excellent affinity and
specificity.  The sensitivity of the
M.tuberculosis (MTB) probe targeting
MTB complex was reported to be 98%.
The sensitivity of NTM probes targeting
NTM species, however, was only 57%
since these do not target all non-
tuberculous mycobacterial species20.
(v) Sherlock mycobacteria identification
system (SMIS):  It uses computerized
software to identify mycobacterial
species on the basis of mycolic acid
pattern generated by HPLC21.
(vi) PCR restriction enzyme analysis:  It
exploits the 65 kDa hsp gene and
16s rRNA gene for  identification
purposes.
(vii) DNA chips:  A technology still under
development that appears promising
involves oligonucleotide arrays or DNA
chips (molecular biology coupled with
computer technology), which have
been designed to determine the specific
nucleotide sequences diversity of the
rpoB and 16S rRNA genes for species
identification22.
Detection and identification of mycobacteria
directly from clinical samples
Both genotypic (molecular) and phenotypic
methods are available with newer modifications for
the diagnosis of tuberculosis as an alternative for
smear microscopy.
Genotypic methods
Polymerase chain reaction :   PCR allows sequences
of DNA present in only a few copies of mycobacteria
to be amplified in vitro such that the amount of
amplified DNA can be visualized and identified.  If
appropriate sequences specific for M.tuberculosis are
selected, 10-1000 organisms can be readily
identified.  The PCR methodology is rapid; results
are available within a day of DNA extraction from
the sample.  A number of target genes of
mycobacterial DNA have been evaluated for
diagnosis by PCR and various other genotypic
methods.  The most common target used in the PCR
is IS6110.  This sequence is specific for
M.tuberculosis complex and is present up to 20 times
in the genome, thus offering multiple targets for
amplification.  PCR detection of IS6110 in sputum
(in pulmonary TB) and peripheral blood (in extra-
pulmonary TB), when compared to culture has a
sensitivity, specificity and positive predictability of
83.5, 99.0 and 94.2% respectively.  A variety of PCR
methods have been described in the search for a
sensitive and reliable screening test for tuberculosis
in clinical specimens.  Species-specific and genus-
specific PCR methods are being used with various
targets and modifications of PCR.  The  following
are some of the methods used for identification of
TECHNIQUES  FOR  DIAGNOSIS  OF  TUBERCULOSIS
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M.tuberculosis and NTM23:
Transcription mediated amplification
(TMA) and nucleic acid amplification (NAA):  This
approach identifies the presence of genetic
information unique to M.tuberculosis complex directly
from pre-processed clinical specimens.  The NAA
technique uses chemical, rather than biological
amplification to produce nucleic acid, so that within
a few hours these tests distinguish between
M.tuberculosis complex and NTM in an AFB positive
specimen.  It is currently used only for respiratory
specimens; use for non-respiratory specimens is
likely in the near future.
A positive direct amplified test in
conjunction with an AFB-positive smear is highly
predictive of tubercular disease.  However, the results
of NAA are preliminary;  mycobacterial culture is
still needed for species identification/confirmation
and for drug-susceptibility testing.  A negative NAA
with an AFB-positve smear indicates that the AFB is
probably NTM.  The M.tuberculosis direct test
(MTD) and amplified mycobacterial direct test
(AMDT) are highly sensitive (96%) and specific
(100%) for M.tuberculosis on specimens that are
smear positive for AFB. However, there are
occasional false-negative or false positive results
being reported, which are either due to the presence
of fewer bacilli or due to contamination.  Another
disadvantage of the technique is that both viable and
dead bacilli can give positive results as the DNA of
both can be amplified.
The ligase chain reaction:  It is a variant of
PCR, in which a pair of oligonucleotides are made to
bind to one of the DNA target strands, so that they are
adjacent to each other.  A second pair of oligonucleotides
is designed to hybridize to the same regions on the
complementary DNA.  The action of DNA polymerase
and ligase in the presence of nucleotides results in the
gap between adjacent primers being filled with the
appropriate nucleotides and ligation of the primers.  The
LCX M.tuberculosis assay kit (Abbot) is mainly being
used for respiratory samples, and has a high overall
specificity and sensitivity for  smear positive and
negative specimens.
Other modifications of the PCR include
strand displacement amplification (SDA), nucleic acid
sequence based amplification (NASBA), branched
DNA (b-DNA) and line probe assay (LiPA).  The list
of the targets in commercially available kits is given
in Table 1.
Table 1. Targets in  commercially available kits
Phenotypic method
FAST Plaque TBTM : This is an original phage based
test, which uses the mycobacteriophage to detect
the presence of M.tuberculosis directly from sputum
specimens.  It is a rapid, manual test, easy to perform
and has a higher overall  sensitivity as  compared to
sputum smear microscopy, in newly diagnosed smear
positive TB patients.  The test has a specificity of
98.7  99.0% and a sensitivity of 70.3  75.2%, as
compared to smear microscopy, which has a
specificity of 97.3  97.4% and a sensitivity of 61.3
 63.4%24,25.
Serological diagnosis of Tuberculosis
Most of the serological tests have low
turn around time, high negative predictive value
and  a re  usefu l  as  sc reen ing  tes t s .   The
limitation of these tests is low sensitivity in
smear negative patients, HIV positive cases, and
in disease endemic countries with a high
infection rate.  The tests are also expensive,
require  t rained personnel  and often have
di f f icu l ty  in  d i s t inguish ing  be tween
M.tuberculosis and NTM.
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Development of antigen detection assay for
diagnosis of TB using sputum samples
Capture ELISA :A quantitative test to detect
lipoarabinomannan (LAM) has been developed for
the detection of TB in urine specimens.  Another
test being used in a field trial is the dipstick method
(semi-quantitative) for the detection of LAM in both
pulmonary and extra-pulmonary specimens.
Preliminary reports have shown a sensitivity and
specificity of 93 and 95% respectively26.
Detection of LAM in sputum : The test is based on
the capture antibody derived from murine source
(murine monoclonal antibody against LAM).  The
rabbit antiserum against M.tuberculosis is used as a
source of detector of the antibody.  The specific
and sensitive assay for the detection of LAM in
sputum is potentially useful for the diagnosis of TB.
Antigen detection in body fluids : The advent of
nucleic acid amplification technology (especially
PCR) has overshadowed recent developments in
antigen detection.  However, free mycobacterial
antigen at a concentration of 3-20ng/ml can be
detected in biological fluids such as cerebrospinal
fluid (CSF) or pleural fluid.  The most commonly
used antigens include mycobacterial sonicates,
extracted glycolipids, PPD, Ag5 (38kDa), Ag A60,
45/47kDa Ag, Ag Kp90, 30 kDa Ag, P32 Ag, cord
factor (trehalose dimycolate) and lipoarabinomannan.
Most of the tests use polyclonal antibodies raised
against crude mycobacterial antigens except for
antigen 5 and LAM.  The sensitivity of tests ranges
from 40-50% and specificity 80-95%. The methods
used for antigen detection are: the sandwich ELISA,
inhibition ELISA, latex agglutination and reverse
passive haemagglutination tests27.
INDIRECT APPROACH
Detection of Antibodies for diagnosis of TB
Antibodies to mycobacterial antigens in sera
of patients are detected either by using monoclonal
or polyclonal antibodies.  Cross-reaction by
environmental mycobacteria is likely to produce false-
positive results.  Reproducible methods for
purification of mycobacterial antigens have yet to
be evolved;  hence the results of most assays available
at present are variable in different settings.  It is also
important to note that the immune response in
mycobacterial disease appears to be associated with
HLA Class II allotypes and different patients appear
to recognize different antigens.  It is thus unlikely
that all tuberculosis patients will recognize a single
antigen, and hence prove to be a handicap for the
development of antibody-based detection systems
for mycobacteria.  Some of the newer approaches
are as follows:
TB STAT-PAK : Immunochromatographic test
based on the detection of antibodies has been evolved
with a capability to differentiate between  active or
dormant TB infection in whole blood, plasma or
serum.  Its value in disease endemic countries such
as India is yet to be ascertained28.
Enzyme immuno assay for the detection of anti-
mycobacterial superoxide dismutase antibody:
Superoxide dismutase is an important secretory
protein of M.tuberculosis and has been evaluated
for the serodiagnosis of tuberculosis.  It is found
to be useful only in low prevalence countries (93-
94% positive predictive value), compared to high
prevalence countries like India and Egypt, where
the positive predictive value drops to 77-88%29.
Insta test TB : It is a rapid in vitro assay for the
detection of antibody in active TB disease using
whole blood or serum.  The test employs an antibody
binding protein conjugated to a colloidal gold particle
and a unique combination of TB antigens immobilized
on the membrane30
Some of the other commercially available
antibody tests for pulmonary TB are listed in Table
2.
Miscellaneous diagnostic methods
To overcome the poor specificity of the
existing skin test based on tuberculin, newer tests
with defined antigens are needed to discriminate
TECHNIQUES  FOR  DIAGNOSIS  OF  TUBERCULOSIS
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between the infected individuals from those with
active disease.  The latest of these is the MPB 64
patch test.
TB MPB 64 patch test : MPB 64 is a specific
mycobacterial antigen for M.tuberculosis complex.
This patch test becomes positive in 3-4 days after
patch application and lasts for a week.  The test has
a specificity of 100% and a sensitivity of 98.1%31.
This promising test has been reported so far only in
one setting in Philippines and needs to be carried out
in other settings.
Another approach is the use of defined
antigens for an accurate and rapid test for tuberculosis
infection based on the detection of T cells sensitized
to M.tuberculosis either by blood tests in vitro or
skin tests in vivo32.  Mononuclear cells from the
peripheral blood are stimulated in vitro and production
of IFN gamma from the sensitized T cells is
measured by ELISA33. The  antigens used are ESAT 6
(early secretory antigen TB) and CFP 10 (culture filtrate
protein), which are being used as  alternatives for
PPD, for use in skin test (tuberculin testing) in vivo.
Measurement of IFN gamma producing cells
The ESAT 6 (6 kDa) is a specific antigen
and a strong inducer of IFN gamma production by
T cells of TB patients.  The M.tuberculosis genome
encompasses regions of differences (RD).  These
RD may encode potential antigens relevant for
protection or diagnosis.  The RD1 region is
responsible for the secretion of ESAT-6 in response
to TB.  This antigen is recognized by T cells of TB
patients and is not recognized by BCG vaccinated or
healthy unvaccinated individuals.  The levels of IFN
gamma increases in treated compared to untreated
patients, and is associated with improved immunity
against TB.  Hence this may be useful for monitoring
TB patients34.
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